Sealonix closes on $20M in funding for orthopedic sealant
Sealonix, a biomaterials company, has closed on $20 million in series A funding to develop their next generation of hemostatic sealants for surgical use. The
Source: beckersspine.com
Stay updated with breaking news from Ealant Patch. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sealonix, a biomaterials company, has closed on $20 million in series A funding to develop their next generation of hemostatic sealants for surgical use. The